@article{article_461546, title={Successful treatment of paliperidone palmitate induced akathisia with mirtazapine: A case report}, journal={Harran Üniversitesi Tıp Fakültesi Dergisi}, volume={15}, pages={259–261}, year={2018}, author={Ayaydın, Hamza and Bilgen Ulgar, Şermin}, keywords={Schizophrenia,Paliperidone palmitate,Akathisia,Mirtazapine,Antipsychotic}, abstract={<p> <span lang="en-us" style="font-size:12pt;line-height:115%;font-family:’Times New Roman’, serif;" xml:lang="en-us">Paliperidone palmitate is a long-acting injectable preparation and is indicated in acute and maintenance treatment of schizophrenia. Akathisia is an extrapyramidal symptom characterized by inner restlessness and the need to keep moving. Although β-blockers, benzodiazepines and anticholinergics have been used in the treatment of antipsychotic-induced akathisia, mirtazapine is also effective in the treatment of antipsychotic-induced akathisia. However, our search of literature did not reveal any cases of use mirtazapine in the treatment of akathisia associated with the use of long-acting antipsychotics. In this case, we used each treatment line to be used in the treatment of akathisia; however, the patient could be stabilized only by mirtazapine. </span> <br /> </p>}, number={3}, publisher={Harran University}